ATE112960T1 - Anthocyanidine zur behandlung von augenkrankheiten. - Google Patents

Anthocyanidine zur behandlung von augenkrankheiten.

Info

Publication number
ATE112960T1
ATE112960T1 AT90308197T AT90308197T ATE112960T1 AT E112960 T1 ATE112960 T1 AT E112960T1 AT 90308197 T AT90308197 T AT 90308197T AT 90308197 T AT90308197 T AT 90308197T AT E112960 T1 ATE112960 T1 AT E112960T1
Authority
AT
Austria
Prior art keywords
anthocyanidins
delphidin
pelargonidin
treatment
eye diseases
Prior art date
Application number
AT90308197T
Other languages
English (en)
Inventor
Maria Jose Magistretti
Marisa Conti
Giorgio Pifferi
Original Assignee
Idb Holding Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idb Holding Spa filed Critical Idb Holding Spa
Application granted granted Critical
Publication of ATE112960T1 publication Critical patent/ATE112960T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
AT90308197T 1989-07-28 1990-07-26 Anthocyanidine zur behandlung von augenkrankheiten. ATE112960T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917323A GB8917323D0 (en) 1989-07-28 1989-07-28 Methods and pharmaceutical compositions for the treatment of ophthalmic diseases

Publications (1)

Publication Number Publication Date
ATE112960T1 true ATE112960T1 (de) 1994-11-15

Family

ID=10660801

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90308197T ATE112960T1 (de) 1989-07-28 1990-07-26 Anthocyanidine zur behandlung von augenkrankheiten.

Country Status (11)

Country Link
US (1) US5196449A (de)
EP (1) EP0410749B1 (de)
JP (1) JP2967523B2 (de)
KR (1) KR0149026B1 (de)
AT (1) ATE112960T1 (de)
DE (1) DE69013431T2 (de)
DK (1) DK0410749T3 (de)
GB (1) GB8917323D0 (de)
HK (1) HK124595A (de)
IT (1) IT1245717B (de)
PT (1) PT94848A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673513B1 (fr) * 1991-03-05 1993-10-29 Institut Recherche Biologique Sa Nouvelles compositions dietetiques a base de lipides phosphoryles et leur utilisation dans l'amelioration des troubles de la vision.
JP3414446B2 (ja) * 1993-07-23 2003-06-09 財団法人相模中央化学研究所 ヒドロキシシリル基を末端に有するポリオキシエチレン化合物、四級塩を末端に有するブロック共重合体、および経皮吸収促進剤
JPH1059846A (ja) * 1996-06-10 1998-03-03 Kikkoman Corp 白内障の予防または治療薬剤
ES2303509T3 (es) 1999-07-02 2008-08-16 Meiji Seika Kaisha, Ltd. Composiciones para alimentos, proceso para su produccion y alimentos y bebidas funcionales que las contienen.
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux
US7014991B2 (en) * 2001-11-16 2006-03-21 Infinite Vision, Llc Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
EP1681297A4 (de) 2003-10-30 2009-06-17 Meiji Seika Kaisha Inhibitor der tyrosinaseaktivität und mittel zum verbessern der durchblutung des gesichts
JP4873904B2 (ja) * 2005-08-22 2012-02-08 国立大学法人弘前大学 眼血管血流障害改善剤
FR2975008B1 (fr) * 2011-05-13 2014-03-07 Inst Biophytis Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla)
JP2013163669A (ja) * 2012-01-12 2013-08-22 Oriza Yuka Kk 可視光誘発網膜障害抑制剤及びそれを用いた眼疾患予防・治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
FR2378272A1 (fr) * 1977-01-25 1978-08-18 Ferodo Sa Dispositif dynamometrique de mesure de couple pour engin a fleche de levage a commande par verin
BE864450R (fr) * 1978-03-01 1978-07-03 Inverni Della Beffa Spa Compositions pharmaceutiques a base d'anthocyanidine, leur preparation et leur utilisation
FR2461499A1 (fr) 1979-07-23 1981-02-06 Inverni Della Beffa Spa Composition pharmaceutique a base d'extraits de myrtille
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
DE3670570D1 (de) * 1986-09-02 1990-05-31 Alcon Lab Inc Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom.

Also Published As

Publication number Publication date
IT9020968A1 (it) 1992-01-18
EP0410749A2 (de) 1991-01-30
DE69013431T2 (de) 1995-02-23
DE69013431D1 (de) 1994-11-24
JPH0381220A (ja) 1991-04-05
DK0410749T3 (da) 1994-11-14
IT9020968A0 (it) 1990-07-18
PT94848A (pt) 1991-04-18
US5196449A (en) 1993-03-23
IT1245717B (it) 1994-10-14
EP0410749B1 (de) 1994-10-19
KR910002442A (ko) 1991-02-25
JP2967523B2 (ja) 1999-10-25
GB8917323D0 (en) 1989-09-13
KR0149026B1 (ko) 1998-10-15
EP0410749A3 (en) 1993-02-03
HK124595A (en) 1995-08-11

Similar Documents

Publication Publication Date Title
ATE420857T1 (de) Prostaglandin-derivate zur behandlung von glaukom und ocularer hypertension
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
ATE241365T1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
DE68902649D1 (de) Lokal anzuwendende arzneizubereitung zur behandlung von entzuendungserkrankungen.
ATE220906T1 (de) Formulierung zur topischen anwendung am auge, die olopatadine enthalten, zur behandlung von allergischen augenerkrankungen
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
DE69930271T8 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
DE69013431D1 (de) Anthocyanidine zur Behandlung von Augenkrankheiten.
ATE131064T1 (de) Behandlung zur ermässigung von ödem und muskelschäden.
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
DE60129322D1 (de) Apoptotische körper zur verwendung in der behandlung von neurodegenerativen und sonstigen nervenerkrankungen
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
RU2071316C1 (ru) Глазные капли для лечения катаракты
DE60027878D1 (de) Verwendung des nervenwachstumfaktors zur herstellung eines arzneimittels zur behandlung von erkrankungen der innenaugegeweb
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
AU643772B2 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
SE8303729D0 (sv) Terapeutiskt medel for behandling av allergiska sjukdomstillstand, immunkomplexsjukdomar och tumorer
ATE203680T1 (de) Konjugat zur behandlung von entzündungserkrankungen
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
RU98119433A (ru) Способ лечения заболеваний роговицы
BG96092A (bg) Тиенотиопиранови сулфонамидни производни и приложението им в офталмологични препарати
RU94000179A (ru) Глазной гель
RU94038765A (ru) Способ лечения десцеметоцеле
RU94040875A (ru) Способ хирургического лечения отслойки сетчатки с использованием тампонирующих веществ

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties